Loading...
Last submissions
-
Jean-Luc Raoul, Marie-Françoise Heymann, Frédéric Dumont, Alain Morel, Hélène Senellart, et al.. Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components. Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.646992⟩. ⟨hal-03623095⟩
-
-
Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, Guilhem Roubaud, Yohann Loriot, et al.. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study. Clinical Genitourinary Cancer, 2021, 19 (4), pp.e216-e222. ⟨10.1016/j.clgc.2021.02.005⟩. ⟨hal-03631553⟩
-
Victoria Corvest, Perrine Marec-Bérard, Cyril Lervat, Hélène D. Pacquement, Maud Toulmonde, et al.. Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France. International Journal of Cancer, 2023, 152 (8), pp.1659-1667. ⟨10.1002/ijc.34326⟩. ⟨hal-04122360⟩
-
Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, et al.. Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩. ⟨hal-03583253⟩
-
-
-
Philippe Cassier, Elena Fumagalli, Piotr Rutkowski, Patrick Schöffski, Martine van Glabbeke, et al.. Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era. Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩. ⟨hal-03623776⟩
-
Marie-Paule Garcia, Henri Der Sarkissian, Erin Mckay, Ludovic Ferrer, Manuel Bardiès, et al.. TestDose : a SPECT image generator for clinical dosimetry studies. SPIE Medical Imaging 2013, SPIE : International Society for Optics and Photonics, Feb 2013, Orlando, United States. pp.1-7, ⟨10.1117/12.2007840⟩. ⟨hal-04084596⟩
-
T. Aparicio, O. Bouché, P. L. Etienne, E. Barbier, L. Mineur, et al.. Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial. Digestive and Liver Disease, 2022, 55 (4), pp.541-548. ⟨10.1016/j.dld.2022.08.036⟩. ⟨inserm-03986083⟩
-
-
Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, et al.. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study). Gynecologic Oncology, 2020, 159, pp.256 - 263. ⟨10.1016/j.ygyno.2020.07.021⟩. ⟨hal-03491450⟩
-
Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, et al.. Molecular Signature of 18 F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study. Journal of Nuclear Medicine, 2022, 63 (7), pp.1008-1013. ⟨10.2967/jnumed.121.262884⟩. ⟨hal-03807107⟩
-
Thomas L Bonneaud, Chloé Lefebvre, Lisa Nocquet, Agnes Basseville, Julie Roul, et al.. Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties. Cell Death and Disease, 2022, 13 (9), pp.787. ⟨10.1038/s41419-022-05214-9⟩. ⟨inserm-03777381⟩
-
Guillaume Janoray, Yoann Pointreau, Marc Alfonsi, Christian Sire, Lionel Geoffrois, et al.. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer, 2020, 133, pp.86 - 93. ⟨10.1016/j.ejca.2020.04.009⟩. ⟨hal-03490774⟩
-
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, et al.. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncology, 2019, 20, pp.1740 - 1749. ⟨10.1016/S1470-2045(19)30486-3⟩. ⟨hal-03489049⟩
-
-
C. Moreau-Bachelard, L. Campion, M. Toulmonde, A. Le Cesne, M. Brahmi, et al.. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG). ESMO Open, 2022, 7 (2), pp.100402. ⟨10.1016/j.esmoop.2022.100402⟩. ⟨hal-03623511⟩
-
Hervé Bonnefoi, Gaetan Macgrogan, Coralie Poncet, Richard Iggo, Fanny Pommeret, et al.. Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer, 2019, 120 (9), pp.913-921. ⟨10.1038/s41416-019-0420-y⟩. ⟨hal-02282586⟩
-
Cecile Vicier, Patrick Sfumato, Nicolas Isambert, Florence Dalenc, Marie Robert, et al.. TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. European Journal of Cancer, 2021, 159, pp.205 - 214. ⟨10.1016/j.ejca.2021.09.040⟩. ⟨inserm-03647613⟩